We hereby submit Monitoring Agency Report for the quarter ended June 30, 2026 (IPO).

YH/SE/40/2026-27 August 13, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai - 400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Subject: Monitoring Agency Report for the quarter ended June 30, 2026 (IPO) Dear Sir/Madam, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, we hereby enclose the Monitoring Agency Report for the quarter ended June 30, 2026, issued by CARE Ratings Limited (“Monitoring Agency”), appointed to monitor the utilisation of the proceeds of the public issue (IPO) of the Company. The Audit Committee has reviewed and took note of the Monitoring Agency Report at its meeting held on August 10, 2026. The said report may also be accessed on the website of the company i.e https://www.yatharthhospitals.com/investors/stakeholders-information/monitoring-agency- report This is for your kind information and records. Thanking You Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166 Encl.: A/a No. CARE/NRO/GEN/2026-27/1105 The Board of Directors Yatharth Hospital and Trauma Care Services Limited N 32 Sector Omega First Greater Noida, Uttar Pradesh 201308 August 13, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026- in relation to the Initial Public Offer of Yatharth Hospital And Trauma Care Services Limited (“the Company”) We write in our capacity of Monitoring Agency for the Initial Public Offer for the amount aggregating to ₹569.71 crore of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated July 15, 2023. Request you to kindly take the same on records. Thanking you, Yours faithfully, Rajan Sukhija Associate Director Rajan.Sukhija@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC07169 Report of the Monitoring Agency Name of the issuer: Yatharth Hospital and Trauma Care Services Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Ongoing delays in the implementation timeline Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Rajan Sukhija Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC07169 1) Issuer Details: Name of the issuer : Yatharth Hospital and Trauma Care Services Limited Name of the promoter : Mr. Ajay Tyagi and Mr. Kapil Kumar Industry/sector to which it belongs : Healthcare- Healthcare Services-Hospital 2) Issue Details Issue Period : July 26,2023 to July 28,2023 Type of issue (public/rights) : Initial Public Offer Type of specified securities : Equity shares IPO Grading, if any : Not Applicable Issue size (in `crore) : Rs. 610 crores 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Comments of Source of information / certifications Comments of the the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of preparation of report Directors The issue proceeds have been utilized in accordance with the objects given as per Whether all utilization is as per the disclosures in the Offer Management Certificate, Chartered offer documents. However, there are No No Comments Document? Accountant certificate, Bank statement ongoing delays in the implementation schedule, and we have not received any requisite approval for the same. Whether shareholder approval has been obtained in case of No material material deviations# from expenditures disclosed in the Offer Management Certificate, CA Certificate Not applicable No Comments deviation Document? Whether the means of finance for the disclosed objects of the No Management Certificate, CA Certificate Not applicable No Comments issue have changed? Is there any major deviation observed over the earlier monitoring Management Certificate, CA Certificate, No Not applicable No Comments agency reports? Monitoring Agency report (Q4FY26) Whether all Government/statutory approvals related to the All the necessary approvals have been Yes Management Certificate, CA Certificate No Comments object(s) have been obtained? obtained by the company. CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC07169 Comments of Source of information / certifications Comments of the the Particulars Reply considered by Monitoring Agency for M [Showing first 8,000 characters — download PDF for full document]